The Latest
-
Q&A
How Aktiia built the first over-the-counter cuffless blood pressure monitor
Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.
-
Retrieved from Luna Health on August 20, 2025
Luna Health raises $23.6M for tiny insulin patch pump
The startup intends to make a small patch pump with a closed-loop algorithm for nighttime glucose control.
-
NeuroOne gains FDA clearance for trigeminal nerve ablation
The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.
-
Medtronic adds 2 board seats, forms special committees
CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott Investment Management.
-
CMR Surgical hires Chris O’Hara to drive US robot expansion
O’Hara joins CMR’s executive team as commercial president and general manager for the U.S., following the FDA’s authorization last fall for its Versius system.
-
Medtronic recall of heart vent catheters tied to 3 serious injuries
The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being bent.”
-
AI in medtech is booming. Track new devices here.
The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of the latest developments in this database.
Updated Aug. 18, 2025 -
Heart devices pace medtech’s summer funding flows
July and August have brought a steady beat of private financings for young medtech companies, with several deals supporting new technologies to treat heart conditions.
-
Philips will spend $150M to expand manufacturing for AI-enabled tech
The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, facility.
-
Apple updates smart watches with blood oxygen feature after customs ruling
Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.
-
Reprieve Cardiovascular raises $61M; Conformal Medical nets $32M for LAAO
The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused companies.
-
Q&A
Shan Jegatheeswaran shares J&J’s vision for AI in the OR
By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in procedures.
-
Trump says semiconductor tariffs to come next week
The president indicated that duties on chips would be “approximately 100%” earlier this month.
-
Vicarious Surgical delays robot timeline
Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by the end of the year.
-
Oracle launches AI-backed EHR
The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch in the acute care market next year.
-
Cardiosense appoints John Martin as chief medical officer
The appointment comes weeks after the company received 510(k) clearance for its wearable heart monitor.
-
Draeger removes ventilation filters over misleading carbon dioxide readings
Hospitals are being advised to stop using the filters after serious injuries were reported related to the problem, the FDA said in a recall notice.
-
SetPoint Medical secures $140M to fund neuromodulation for arthritis
Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month.
-
Heartflow’s IPO raises $364M
The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid investor enthusiasm.
-
Hospitals prepare for $149B cut to Medicaid state-directed payments
New limits to the program could force hospitals to slash capital spending while bracing for millions of newly uninsured patients.
-
US to maintain lower tariff rates on China imports for 90 more days
China also extended its suspension of additional retaliatory duties against U.S. goods, maintaining current rates until November.
-
Apreo raises $130M for pivotal trial of emphysema device
The company, which received investment from the venture capital wing of Intuitive Surgical, has designed the device to work in a broader patient population than existing treatments.
-
Boston Scientific updates instructions of devices linked to 17 deaths
The update covers devices used in procedures to implant the company’s Watchman heart device.
-
Tandem, Insulet monitoring CMS payment proposal for diabetes tech
The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for diabetes devices, if finalized.
-
Tandem insulin pump malfunction linked to 59 injuries
A problem with speakers in Tandem’s t:slim X2 insulin pumps can cause insulin delivery to stop, the company said.